Shareholders received one share of seed company Vylor for each Corteva share before Thursday's open, while a challenge from 19 states remains unresolved.
Investors scanning premarket screens on Thursday saw Corteva down 56.6% at $33.89, against a Wednesday close of $77.87. The number is real, but it does not mean what it appears to mean.
The decline is the mechanical result of Corteva's separation of its seed business into a new company, Vylor. Shareholders of record on were due to receive one Vylor share for each Corteva share before the market opened Thursday. Vylor begins regular-way trading on the New York Stock Exchange the same day, under the ticker VYLR. There was no when-issued trading ahead of the distribution.
What the market is implying
The arithmetic offers a first estimate of what investors think Vylor is worth. If Corteva's premarket price holds and the combined value of the two companies matches Wednesday's close, each Vylor share would be valued at about $43.98. On those numbers the seed business would account for roughly 56% of the old company's value, with the remaining crop-protection business at about 44%.
That estimate will be tested quickly. Spinoffs often trade apart from the pre-separation total as index funds and other holders rebalance, sometimes selling the new shares that no longer fit their mandates.
The legal cloud
The separation proceeded despite a challenge from 19 states, Puerto Rico and the District of Columbia. In federal court in South Carolina, they asked for a temporary restraining order and preliminary injunction to block the split, arguing it would shift about $39 billion of value to Vylor while leaving only $3.56 billion of cash to cover potential liabilities tied to PFAS, the so-called forever chemicals. Corteva rejects the claims.
The court had not ruled on the states' motion by early Thursday. A ruling in their favor after the distribution would raise difficult questions about how to unwind or condition a separation that has already happened.
Why the split matters
The logic of the transaction is to separate a seed business with steadier, research-driven growth from a chemicals operation carrying environmental litigation risk. If the market values the two pieces at more than the combined company was worth, the spinoff will have created value. If the PFAS overhang depresses the remaining Corteva, the gain may be smaller than management hoped.
What to watch
The first regular-session closing prices of Corteva and Vylor will establish whether the sum of the parts exceeds $77.87. Any ruling from the South Carolina court on the states' motion would be the other key event.